MedTrace Logo

China Salt Substitute Study

NCT00145756 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2005-09-05

No results posted yet for this study

Summary

Cardiovascular disease is a leading cause of death and disability worldwide, and blood pressure is a leading determinant of this risk. To date, strategies for blood pressure lowering have focused on drug treatment but dietary interventions such as reducing sodium intake and increasing potassium intake may also be effective. Such interventions may be particularly suitable for low- and middle-income countries in which significant dietary changes may be more easily achieved. This study will test the effect of a salt substitute on blood pressure, among individuals at high-risk from cardiovascular disease in Northern China.

Conditions

Interventions

DRUG

low sodium high potassium salt substitute

Sponsors & Collaborators

  • Fu Wai Cardiovascular Institute and Hospital

    collaborator UNKNOWN

  • University of Auckland, New Zealand

    collaborator OTHER

  • James Cook University, Queensland, Australia

    collaborator OTHER

  • The George Institute

    lead OTHER

Principal Investigators

  • Bruce C Neal, PhD · The George Institute

  • Yangfeng Wu, PhD · Fu Wai Cardiovascular Institute, Beijing, China

  • Rachel Huxley, PhD · The George Institute

  • John Prescott, PhD · James Cook University, Queensland, Australia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-05-31
Completion
2005-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00145756 on ClinicalTrials.gov